Crossmark

OIP5 Expression Sensitize Glioblastoma Cells to Lomustine Treatment

Crossref DOI link: https://doi.org/10.1007/s12031-018-1184-1

Published Online: 2018-10-03

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rodrigues-Junior, Dorival Mendes

Biassi, Thaís Priscila

Carlin, Viviane

Buri, Marcus Vinicius

Torrecilhas, Ana Claudia

Bortoluci, Karina Ramalho

Vettore, André Luiz
Funding

Funding for this research was provided by:

Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/14837-7, 2010/20218-2)

Fundação de Amparo à Pesquisa do Estado de São Paulo (2011/15118-1, 2012/01597-8)

Conselho Nacional de Desenvolvimento Científico e Tecnológico (300936/2015-0)
License Information

Text and Data Mining valid from 2018-10-03
More Information

Article History

Received: 22 April 2018

Accepted: 24 September 2018

First Online: 3 October 2018

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: This work was approved by the ethics committees of the São Paulo Federal University (CEP-UNIFESP) number 1015/11.